225 related articles for article (PubMed ID: 8702917)
1. A potential SH3 domain-binding site in the Crk SH2 domain.
Anafi M; Rosen MK; Gish GD; Kay LE; Pawson T
J Biol Chem; 1996 Aug; 271(35):21365-74. PubMed ID: 8702917
[TBL] [Abstract][Full Text] [Related]
2. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
[TBL] [Abstract][Full Text] [Related]
3. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
[TBL] [Abstract][Full Text] [Related]
4. Interaction in vitro of the product of the c-Crk-II proto-oncogene with the insulin-like growth factor I receptor.
Koval AP; Blakesley VA; Roberts CT; Zick Y; Leroith D
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):923-32. PubMed ID: 9480911
[TBL] [Abstract][Full Text] [Related]
5. Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein.
Rosen MK; Yamazaki T; Gish GD; Kay CM; Pawson T; Kay LE
Nature; 1995 Mar; 374(6521):477-9. PubMed ID: 7700361
[TBL] [Abstract][Full Text] [Related]
6. The SH3 domain of Crk binds specifically to a conserved proline-rich motif in Eps15 and Eps15R.
Schumacher C; Knudsen BS; Ohuchi T; Di Fiore PP; Glassman RH; Hanafusa H
J Biol Chem; 1995 Jun; 270(25):15341-7. PubMed ID: 7797522
[TBL] [Abstract][Full Text] [Related]
7. Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase.
Nakamoto T; Sakai R; Ozawa K; Yazaki Y; Hirai H
J Biol Chem; 1996 Apr; 271(15):8959-65. PubMed ID: 8621540
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
Tanaka M; Gupta R; Mayer BJ
Mol Cell Biol; 1995 Dec; 15(12):6829-37. PubMed ID: 8524249
[TBL] [Abstract][Full Text] [Related]
9. Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.
Sriram G; Jankowski W; Kasikara C; Reichman C; Saleh T; Nguyen KQ; Li J; Hornbeck P; Machida K; Liu T; Li H; Kalodimos CG; Birge RB
Oncogene; 2015 Aug; 34(32):4260-9. PubMed ID: 25381819
[TBL] [Abstract][Full Text] [Related]
10. Proline-rich sequences mediate the interaction of the Arg protein tyrosine kinase with Crk.
Wang B; Mysliwiec T; Feller SM; Knudsen B; Hanafusa H; Kruh GD
Oncogene; 1996 Oct; 13(7):1379-85. PubMed ID: 8875975
[TBL] [Abstract][Full Text] [Related]
11. Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn.
Panchamoorthy G; Fukazawa T; Stolz L; Payne G; Reedquist K; Shoelson S; Songyang Z; Cantley L; Walsh C; Band H
Mol Cell Biol; 1994 Sep; 14(9):6372-85. PubMed ID: 7520528
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of Crk on tyrosine 251 in the RT loop of the SH3C domain promotes Abl kinase transactivation.
Sriram G; Reichman C; Tunceroglu A; Kaushal N; Saleh T; Machida K; Mayer B; Ge Q; Li J; Hornbeck P; Kalodimos CG; Birge RB
Oncogene; 2011 Nov; 30(46):4645-55. PubMed ID: 21602891
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the amino-terminal SH3 domain of CRK and its natural target proteins.
Matsuda M; Ota S; Tanimura R; Nakamura H; Matuoka K; Takenawa T; Nagashima K; Kurata T
J Biol Chem; 1996 Jun; 271(24):14468-72. PubMed ID: 8662907
[TBL] [Abstract][Full Text] [Related]
14. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites.
Ren R; Ye ZS; Baltimore D
Genes Dev; 1994 Apr; 8(7):783-95. PubMed ID: 7926767
[TBL] [Abstract][Full Text] [Related]
15. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase.
Hunter S; Burton EA; Wu SC; Anderson SM
J Biol Chem; 1999 Jan; 274(4):2097-106. PubMed ID: 9890970
[TBL] [Abstract][Full Text] [Related]
16. Crk family adaptor proteins trans-activate c-Abl kinase.
Shishido T; Akagi T; Chalmers A; Maeda M; Terada T; Georgescu MM; Hanafusa H
Genes Cells; 2001 May; 6(5):431-40. PubMed ID: 11380621
[TBL] [Abstract][Full Text] [Related]
17. Interaction between focal adhesion kinase and Crk-associated tyrosine kinase substrate p130Cas.
Polte TR; Hanks SK
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10678-82. PubMed ID: 7479864
[TBL] [Abstract][Full Text] [Related]
18. Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of Crk.
Knudsen BS; Feller SM; Hanafusa H
J Biol Chem; 1994 Dec; 269(52):32781-7. PubMed ID: 7806500
[TBL] [Abstract][Full Text] [Related]
19. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
Reichman C; Singh K; Liu Y; Singh S; Li H; Fajardo JE; Fiser A; Birge RB
Oncogene; 2005 Dec; 24(55):8187-99. PubMed ID: 16158059
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine-phosphorylated Cbl binds to Crk after T cell activation.
Sawasdikosol S; Chang JH; Pratt JC; Wolf G; Shoelson SE; Burakoff SJ
J Immunol; 1996 Jul; 157(1):110-6. PubMed ID: 8683103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
